The Accompanying Changes in Brain Structure of a Remitted Depression Patient with the Bupropion Treatment

키워드

참고문헌 (10)

1. Takeuchi H., "Regional gray matter volume of dopaminergic system associate with creativity : evidence from voxel-based morphometry", Neuroimage, 51, pp.578~585 (2010)
2. Groman SM., "Methamphetamine-induced increases in putamen gray matter associate with inhibitory control", Psychopharmacology(Berl), 229, pp.527~538 (2013)
3. Kornhuber J., "The role of ceramide in major depressive disorder", Eur Arch Psychiatry Clin Neurosci, 259(Suppl 2), pp.S199~S204 (2009)
4. Witkin JM., "Metabotropic glutamate receptors in the control of mood disorders", CNS Neurol Disord Drug Targets, 6, pp.87~100 (2007)
5. Konradi C., "Antipsychotic drugs and neuroplasticity : insights into the treatment and neurobiology of schizophrenia", Biol Psychiatry, 50, pp.729~742 (2001)
6. Parikh V., "Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol", Neurosci Lett, 356, pp.135~139 (2004)
7. Wang HD., "Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat", Neuropsychopharmacology, 29, pp.1230~1238 (2004)
8. Duncan GE., "Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism", J Pharmacol Exp Ther, 293, pp.8~14 (2000)
9. Durand-Dubief F., "Reliability of longitudinal brain volume loss measurements between 2 sites in patients with multiple sclerosis : comparison of 7 quantification techniques", AJNR Am J Neuroradiol, 33, pp.1918~1924 (2012)
10. Takao H., "Effect of scanner in longitudinal studies of brain volume changes", J Magn Reson Imaging, 34, pp.438~444 (2011)

관련 논문AI추천